Your session is about to expire
← Back to Search
Exposure Therapy for Child Anxiety (IMPACT Trial)
IMPACT Trial Summary
This trial will compare the effectiveness of three different types of treatment for anxiety disorders in children and adolescents. The three types of treatment are cognitive behavioral therapy with exposure (CBT), patient-centered telehealth CBT (PCT-CBT; patient-centered telehealth closed as of 5/1/21), and traditional outpatient CBT. The trial will involve 379 participants who will be randomly assigned to one of the three treatment groups. The primary outcome measures will be the changes in the participants' anxiety symptoms, functioning, and quality of life from baseline to follow-up.
IMPACT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowIMPACT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.IMPACT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a responsible and stable parent or guardian who can be involved in your treatment.I have been diagnosed with anxiety or OCD as my main health issue.I am starting treatment for another major mental health condition.You have symptoms of severe confusion or seeing or hearing things that aren't real.You have a conduct disorder.You are currently having strong thoughts of hurting yourself.I am currently undergoing psychotherapy.My psychotropic medication dose is changing.I need medical care but can go home after.I am between the ages of 5 and 18.I need medical care that does not require hospital stay.My symptoms have lasted for at least 3 months.I have been diagnosed with anxiety or OCD.My symptoms have lasted for at least 3 months.You have been diagnosed with mental retardation.I am between the ages of 5 and 18.
- Group 1: patient-centered home CBT
- Group 2: Provider-centered
- Group 3: patient-centered telehealth CBT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the chief goals of this medical investigation?
"The primary purpose of this clinical trial, which is monitored over a period ranging from 6-12 months, is to assess Pediatric Anxiety Rating Scale. Secondary objectives include the Client Satisfaction Questionnaire-8 (CSQ-8), Homework Compliance Form and Exposure Guide - three measures employed by researchers to gauge consumer satisfaction with mental health services, track homework completion between therapy sessions, and measure therapeutic fidelity/quality respectively."
Are there any qualifications for me to be accepted into the clinical trial?
"This scientific investigation is seeking 379 candidates aged between 5 and 18 with selective mutism. To be admitted, they must have been experiencing symptoms for at least 3 months; require outpatient care; possess a primary or secondary DSM-V diagnosis of anxiety disorder or OCD; and have an adult guardian who is willing to take part in the treatment process."
How many participants are being enlisted in this clinical experiment?
"Indeed, details on clinicaltrials.gov demonstrate that this experiment is presently recruiting participants. It was first publicized online on July 1st 2018 and most recently updated on August 2nd 2022; it seeks to enroll 379 individuals from a single centre."
Are those under the age of fifty-five admissible to participate in this experiment?
"This medical experiment seeks to enrol patients between the ages of 5 and 18."
Is enrollment open for this research experiment?
"Based on the details found on clinicaltrials.gov, this trial is actively looking for volunteers to participate in it. Initially posted on July 1st 2018 and last modified August 2nd 2022, the medical research could benefit from more participants."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger